(Q35144569)

English

Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

title

Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials (English)

1 reference

stated in

Europe PubMed Central

6 August 2017

phase I clinical trial

0 references

phase III clinical trial

0 references

author name string

Maria Pavlaki

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

12784996

retrieved

6 August 2017

Stanley Zucker

series ordinal

2

1 reference

stated in

Europe PubMed Central

6 August 2017

1 June 2003

1 reference

stated in

Europe PubMed Central

6 August 2017

Cancer and Metastasis Reviews

1 reference

stated in

Europe PubMed Central

6 August 2017

22

1 reference

stated in

Europe PubMed Central

6 August 2017

177-203

1 reference

stated in

Europe PubMed Central

6 August 2017

2-3

1 reference

stated in

Europe PubMed Central

6 August 2017

https://scigraph.springernature.com/pub.10.1023/a:1023047431869

0 references

Identifiers

DOI

10.1023/A:1023047431869

1 reference

stated in

Europe PubMed Central

PubMed ID

12784996

retrieved

6 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

PubMed ID

12784996

retrieved

6 August 2017

(Q35144569)

Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)